These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 29374487)

  • 1. Current trials for frontline therapy of mantle cell lymphoma.
    Steiner RE; Romaguera J; Wang M
    J Hematol Oncol; 2018 Jan; 11(1):13. PubMed ID: 29374487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Risk Mantle Cell Lymphoma in the Era of Novel Agents.
    Nabrinsky E; Danilov AV; Koller PB
    Curr Hematol Malig Rep; 2021 Feb; 16(1):8-18. PubMed ID: 33507515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging therapies in mantle cell lymphoma.
    Hanel W; Epperla N
    J Hematol Oncol; 2020 Jun; 13(1):79. PubMed ID: 32552760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapies in mantle cell lymphoma: a pathway to chemotherapy-free strategies.
    Nastoupil LJ; Koff JL; Flowers CR
    Oncology (Williston Park); 2013 Oct; 27 Suppl 2():8-12. PubMed ID: 25374999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mantle cell lymphoma: insights into therapeutic targets at the preclinical level.
    Klener P
    Expert Opin Ther Targets; 2020 Oct; 24(10):1029-1045. PubMed ID: 32842810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances and future directions in mantle cell lymphoma research: report of the 2016 mantle cell lymphoma consortium workshop.
    Kahl BS; Dreyling M; Gordon LI; Quintanilla-Martinez L; Sotomayor EM
    Leuk Lymphoma; 2017 Jul; 58(7):1561-1569. PubMed ID: 28140709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.
    Mangel J; Buckstein R; Imrie K; Spaner D; Crump M; Tompkins K; Reis M; Perez-Ordonez B; Deodhare S; Romans R; Pennell N; Robinson JB; Hewitt K; Richardson P; Lima A; Pavlin P; Berinstein NL
    Semin Oncol; 2002 Feb; 29(1 Suppl 2):56-69. PubMed ID: 11842390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mantle cell lymphoma: evolving management strategies.
    Campo E; Rule S
    Blood; 2015 Jan; 125(1):48-55. PubMed ID: 25499451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal management of mantle cell lymphoma in the primary setting.
    Tang C; Kuruvilla J
    Expert Rev Hematol; 2019 Sep; 12(9):715-721. PubMed ID: 31268728
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma.
    Munger CM; Hegde GV; Weisenburger DD; Vose JM; Joshi SS
    Cancer Immunol Immunother; 2012 Oct; 61(10):1819-32. PubMed ID: 22441656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-chemotherapy Options for Newly Diagnosed Mantle Cell Lymphoma.
    Takiar R; Phillips T
    Curr Treat Options Oncol; 2021 Sep; 22(11):98. PubMed ID: 34524546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
    Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
    Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refining the Mantle Cell Lymphoma Paradigm: Impact of Novel Therapies on Current Practice.
    Avivi I; Goy A
    Clin Cancer Res; 2015 Sep; 21(17):3853-61. PubMed ID: 26059189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents.
    Inamdar AA; Goy A; Ayoub NM; Attia C; Oton L; Taruvai V; Costales M; Lin YT; Pecora A; Suh KS
    Oncotarget; 2016 Jul; 7(30):48692-48731. PubMed ID: 27119356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mantle cell lymphoma: are current therapies changing the course of disease?
    Geisler C
    Curr Oncol Rep; 2009 Sep; 11(5):371-7. PubMed ID: 19679012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapies for mantle cell lymphoma: current challenges and a brighter future.
    Skarbnik AP; Smith MR
    Discov Med; 2013 Mar; 15(82):177-87. PubMed ID: 23545046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antibody drug conjugate VLS-101 targeting ROR1 is effective in CAR T-resistant mantle cell lymphoma.
    Jiang VC; Liu Y; Jordan A; McIntosh J; Li Y; Che Y; Jessen KA; Lannutti BJ; Wang M
    J Hematol Oncol; 2021 Aug; 14(1):132. PubMed ID: 34454548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current overview and treatment of mantle cell lymphoma.
    Schieber M; Gordon LI; Karmali R
    F1000Res; 2018; 7():. PubMed ID: 30109020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current strategies in the treatment of advanced stage mantle cell lymphoma].
    Lenz G; Dreyling M; Unterhalt M; Hiddemann W
    Dtsch Med Wochenschr; 2004 Nov; 129(45):2429-33. PubMed ID: 15529247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Molecular Biology and Targeted Therapy of Mantle Cell Lymphoma.
    Klener P
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.